GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Holdco Nuvo Group DG Ltd (NAS:NUVO) » Definitions » Beneish M-Score

Holdco Nuvo Group DG (Holdco Nuvo Group DG) Beneish M-Score : 0.00 (As of May. 27, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Holdco Nuvo Group DG Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Holdco Nuvo Group DG's Beneish M-Score or its related term are showing as below:

During the past 3 years, the highest Beneish M-Score of Holdco Nuvo Group DG was 0.00. The lowest was 0.00. And the median was 0.00.


Holdco Nuvo Group DG Beneish M-Score Historical Data

The historical data trend for Holdco Nuvo Group DG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holdco Nuvo Group DG Beneish M-Score Chart

Holdco Nuvo Group DG Annual Data
Trend Dec21 Dec22 Dec23
Beneish M-Score
- - -

Holdco Nuvo Group DG Semi-Annual Data
Dec21 Dec22 Dec23
Beneish M-Score - - -

Competitive Comparison of Holdco Nuvo Group DG's Beneish M-Score

For the Medical Devices subindustry, Holdco Nuvo Group DG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Holdco Nuvo Group DG's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Holdco Nuvo Group DG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Holdco Nuvo Group DG's Beneish M-Score falls into.



Holdco Nuvo Group DG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Holdco Nuvo Group DG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * +0.528 * +0.404 * +0.892 * +0.115 *
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * +4.679 * -0.327 *
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $0.04 Mil.
Revenue was $0.18 Mil.
Gross Profit was $-0.02 Mil.
Total Current Assets was $1.58 Mil.
Total Assets was $3.49 Mil.
Property, Plant and Equipment(Net PPE) was $0.74 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.21 Mil.
Selling, General, & Admin. Expense(SGA) was $8.29 Mil.
Total Current Liabilities was $30.95 Mil.
Long-Term Debt & Capital Lease Obligation was $0.95 Mil.
Net Income was $-33.66 Mil.
Gross Profit was $-18.02 Mil.
Cash Flow from Operations was $-14.96 Mil.
Total Receivables was $0.00 Mil.
Revenue was $0.00 Mil.
Gross Profit was $0.00 Mil.
Total Current Assets was $2.61 Mil.
Total Assets was $3.75 Mil.
Property, Plant and Equipment(Net PPE) was $0.91 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.50 Mil.
Selling, General, & Admin. Expense(SGA) was $10.91 Mil.
Total Current Liabilities was $42.04 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.04 / 0.176) / (0 / 0)
=0.227273 /
=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0 / 0) / (-0.015 / 0.176)
= / -0.085227
=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1.577 + 0.741) / 3.486) / (1 - (2.605 + 0.909) / 3.748)
=0.335055 / 0.062433
=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.176 / 0
=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.495 / (0.495 + 0.909)) / (0.206 / (0.206 + 0.741))
=0.352564 / 0.217529
=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8.294 / 0.176) / (10.913 / 0)
=47.125 /
=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.949 + 30.945) / 3.486) / ((0 + 42.044) / 3.748)
=9.149168 / 11.217716
=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-33.655 - -18.017 - -14.956) / 3.486
=-0.19564

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.


Holdco Nuvo Group DG Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Holdco Nuvo Group DG's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Holdco Nuvo Group DG (Holdco Nuvo Group DG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
94 Yigal Alon Street, Alon Tower 1, Tel Aviv, ISR, 6789155
Holdco Nuvo Group DG Ltd is a women's health and connected pregnancy care company and has developed INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform that enables the delivery of remote non-stress tests and maternal and fetal heart rate monitoring, helping expectant mothers adhere to their prescribed care plan. It is leading the transformation from a world where pregnancy care is limited by outdated technology and barriers to accessing care to a world where data-driven, clinically relevant, actionable insights can be accessed both at home and in the clinic. INVU is composed of a hardware component (wearable), with digital signal processing and cloud analytics, and interfaces for every participant involved in pregnancy care.

Holdco Nuvo Group DG (Holdco Nuvo Group DG) Headlines